RecruitingPhase 1NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: AstraZeneca
Palo Alto, CA · San Diego, CA · +10 more sites
Prostate Cancer clinical trials in San Diego, CA
17 recruiting prostate cancer studies with a site in San Diego, CA.
RecruitingPhase 3NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Sponsor: Pfizer
Anaheim, CA · Fountain Valley, CA · Glendale, CA · +36 more sites
RecruitingPhase 4NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Sponsor: Blue Earth Diagnostics
San Diego, CA · +5 more sites
RecruitingPhase 2NCT06632977
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Sponsor: Alliance for Clinical Trials in Oncology
Chico, CA · Encinitas, CA · Irvine, CA · +105 more sites
RecruitingPhase 3NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Sponsor: Alliance for Clinical Trials in Oncology
Bakersfield, CA · Irvine, CA · +135 more sites
RecruitingPhase not listedNCT07543757
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Sponsor: Sequenom, Inc.
San Diego, CA · +6 more sites
RecruitingPhase not listedNCT07124000
DESTINY-PANTUMOUR04
Sponsor: AstraZeneca
San Diego, CA · +17 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Fountain Valley, CA · La Jolla, CA · Los Alamitos, CA · +56 more sites
RecruitingPhase 2NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Sponsor: AstraZeneca
Los Angeles, CA · San Diego, CA · Santa Rosa, CA · +15 more sites
RecruitingPhase 2NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Sponsor: Astellas Pharma Global Development, Inc.
San Diego, CA · +11 more sites
RecruitingPhase 2NCT07111507
A Study of Tarlatamab for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
San Diego, CA · San Francisco, CA · +8 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Arroyo Grande, CA · Burbank, CA · Carmichael, CA · +338 more sites
RecruitingPhase 2NCT04363164
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
San Diego, CA · +5 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Anaheim, CA · Arroyo Grande, CA · Baldwin Park, CA · +371 more sites
RecruitingPhase not listedNCT03151629
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Sponsor: Prostate Cancer Clinical Trials Consortium
Los Angeles, CA · San Diego, CA · +46 more sites
RecruitingPhase 2NCT06134232
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
Duarte, CA · Fresno, CA · San Diego, CA · +28 more sites
RecruitingPhase not listedNCT06579417
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Sponsor: University of California, San Diego
San Diego, CA · San Francisco, CA · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.